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During an image-based phenotype screening of our
chemical library, we noted a small molecule that
boosts the adhesion and growth of human cells.
Chemical and cell biological experiments suggest
that the diaryldispirotripiperazine derivative (adhes-
amine) targets selective cell-surface glycosamino-
glycans, especially heparan sulfate, for increasing
cell adhesion and growth. The addition of adhes-
amine to the culture medium enables the adhesion
of even floating lymphocytes to cell culture plates
and the microinjection into them. Unlike poly-L-
lysine, adhesamine induces apparently normal cell
adhesion accompanied by organized actin struc-
tures and activation of focal adhesion kinase and
ERK1/2 mitogen-activated protein kinases. Adhes-
amine may be useful as a cell-attaching reagent for
cell engineering and basic cell biology.
INTRODUCTION
Interactions between cell and extracellular matrix are pivotal for
the survival of adherent cells, both in vivo and in vitro (Howe
et al., 2002). In vitro maintenance of adherent cells can be
promoted by coating culture plates with artificial substrates,
including native extracellular matrix molecules derived from
either human/animal tissues or recombinant bacteria. However,
many of these native molecules are not chemically defined and
have the risk of contamination (Koide, 2005). Chemically defined
synthetic polycationic peptides, such as poly(L/D-lysine), are
alsowidely used for coating cell culture dishes. Such nonspecific
adhesive coatings, however, may cause abnormal cell spread-
ing, leading to cytotoxic or physiologically irrelevant outcomes
(Bershadsky et al., 1996).
A syntheticmolecule that promotesphysiological cell adhesion
would serve as a convenient reagent for a reproducible, safe, and
biocompatible cell culture. Here, we report the discovery of the
first, to our knowledge, nonpeptidic organic molecule whose
simple addition induces apparently normal cell adhesion to
culture plates. Chemical and cell biological experiments suggest
that adhesamine is most likely to exert its cell-adhesion activityChemistry & Biology 16,by interactingwith selective sulfatedglysosaminoglycans (GAGs)
to modulate cell-surface properties and intercellular signaling
pathways.
RESULTS
Discovery of Adhesamine
During an image-based phenotype screening of our chemical
library (30,000 synthetic molecules), we noted a small molecule
that has an intriguing effect on human hepatoma (HepG2) cells.
In the presence of the dispirotripiperazine derivative, which we
named adhesamine (1), HepG2 cells seemed to attach more
readily to culture plates (Figures 1A and 1B).
To confirm that the molecule promotes cell adhesion, reat-
tachment of trypsinized HepG2 cells to a culture plate was
examined in the presence of 0.6–60 mMadhesamine. A 3 hr incu-
bation time was used, because HepG2 cells began to attach to
the culture plate within 3 hr of seeding. The plates were washed
with phosphate-buffered saline (PBS) to remove unattached
cells, and adhered cells remaining on the plate were counted
(Lutolf and Hubbell, 2005). The results showed that adhesamine
enhances the adhesion of HepG2 cells by up to 2 fold and that
the effect is dose dependent (Figure 1E).
HepG2 cells have an intrinsic propensity to adhere to plastic
tissue-culture plates. Therefore, we tested adhesamine with
the Jurkat cell line, human T lymphocytes that are usually
cultured as floating cells. Remarkably, 30% and 60% of the
Jurkat cells attached to a culture plate in the presence of 6 and
60 mM of adhesamine, respectively (Figure 1F). Removal of
adhesamine by washing the plate twice with PBS detached the
cells: 93% of Jurkat cells were released from the surface of
a culture plate 24 hr after washing (see Figure S1 available
online). The results indicate that the effect of adhesamine is
reversible. It is noteworthy that adhesamine did not induce cell
aggregation or cell-cell adhesion. The addition of adhesamine
to the medium promoted adhesion of Jurkat cells to the plastic
surface of culture plates but not to each other.
Characterization of Adhesamine-Induced Cell Adhesion
Adhesamine had no obvious cytotoxicity in the cell lines we
tested, even at 60 mM, which is close to the highest possible
concentration in aqueous solution, and it enhanced the growth
of the cells in a dose-dependent manner up to this range of
concentrations (Figures 2A and 2B and Figure S2). Although773–782, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 773
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Discovery and Mechanism of Adhesamine60 mM of adhesamine had the highest effects on cell adhesion
and growth, this concentration was too close to the solubility
limit of adhesamine for practical use, and 6 mM of adhesamine
exhibited clear activity in Jurkat cells. For these reasons, 6 mM
was used for further investigations.
Themorphologyof thecells treatedwith adhesamine appeared
normal, as well-maintained HepG2 and Jurkat cells (Figure 1).
Visualization of actin cytoskeletons with rhodamine-conjugated
phalloidin revealed the F-actin networks in adhered cells: actin
filament bundles ran in parallel to the cell axis or through cell
processes in HepG2 cells, and well-organized cortical actin
structure, which is reminiscent of the survival phenotype, formed
in Jurkat cells (Figure 2C and Figure S3). Although adhesamine-
treated cells formed organized actin structure, those in poly-L-
lysine-coatedwells formed relatively few cytoplasmic actin fibers
(Figure 2D and Figure S3). Instead, poly-L-lysine-treated cells
showed some clumps or filamentous actin aggregates, which
are often accompanied by decreased viability.
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Figure 1. Promotion of Cell Attachment by
Adhesamine (1)
(A and B) HepG2 cells incubated with 1% (v/v)
DMSO alone (A) or 6 mM adhesamine (B).
(C and D) Jurkat cells incubated with 1% (v/v)
DMSO alone (C) or 6 mM adhesamine (D).
(E and F) Adhesion rates of HepG2 cells (E) or Ju-
rkat cells (F) when 0–60 mM of adhesamine was
added to the culture media. Each point represents
the mean ± SD.
The cells were also immunostained
with an antibody against vincullin, a
marker of focal adhesion. Vincullin-con-
taining focal adhesions were observed
in adhesamine-treated cells immediately
after seeding, when nontreated cells or
those seeded onto poly-L-lysine-coated
wells had not yet formed focal contacts
(Figures 2E and 2F and Figures S4 and
S5). These observations indicate that
the adhesamine-induced contacts of
the cells to the plates initiate a normal
schedule of cell adhesion (Huo et al.,
2004; Parsey and Lewis, 1993).
To further examine the adhesamine-
mediated adhesion, the effects of cy-
toskeletal disruption were evaluated.
Adhesion assays were performed after
treatment with cytochalasin B or nocoda-
zole, drugs that disrupt actin filaments
and microtubules, respectively (Arroyo
et al., 1992; Kinch et al., 1993). Both cyto-
chalasin B and nocodazole inhibited the
adhesamine-mediated cell adhesion in
a dose-responsive manner, just as they
impaired the fibronectin-mediated cell
adhesion. In contrast, the two reagents
had no detectable effects on the cell
attachment induced by poly-L-lysine
(Figures 2G and 2H). These data collectively suggest that adhes-
amine induces cell adhesion similar to that induced by native
extracellular matrix.
Structure-Activity Relationship Studies
To analyze the mechanism of the adhesamine-induced cell
adhesion, we conducted structure-activity relationship studies
of adhesamine. One prominent structural component of adhes-
amine (1) is the positively charged, highly constrained dispirotri-
piperazine moiety. Substitution of the dispirotripiperazine moiety
with a less rigid and tertiary amine linker, dipiperazylethane
(molecule 2), completely abolished the cell-attaching activity in
Jurkat cells (Figure 3A). Two tetraammonium cations were
reintroduced to 2 by methylating the two nitrogen atoms in the
dipiperazylethane linker. The resulting methylpiperazium deriva-
tive 3 exhibited no activity, underscoring the importance of the
fixed conformation of the positively charged dispirotripiperazine
moiety.774 Chemistry & Biology 16, 773–782, July 31, 2009 ª2009 Elsevier Ltd All rights reserved
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Figure 2. Effects of Adhesamine (1) on the Cell Growth and Cyto-
skeletal Networks
(A andB) Promotion of cell growth by 1. The growth rates ofHepG2 (A) or Jurkat
(B) cells were determined 24, 48, and 72 hr after the addition of 1 (6 mM). The cell
growth in thepresenceof 1% (v/v)DMSOwasassignedas avalueof 100%.The
data shown are means ± SD for a minimum of three experiments.
(C–F) The rearrangement of actin fibers (C, D) and the formation of focal adhe-
sion (E, F) in HepG2. Trypsinized HepG2 cells were plated for 3 hr on adhes-
amine-added or poly-L-lysine-coated coverslips. The concentrations of
adhesamine and poly-L-lysine were 6 mM and 5 mg/ml, respectively. Actin
cytoskeleton was visualized with rhodamine-conjugated phalloidin. Focal
adhesions were visualized with anti-vinculin antibody.
(G and H) Effects of cytoskeletal disruption on adhesamine-induced cell adhe-
sion. Jurkat cells were attached to a plastic plate by adding adhesamine in the
presence of nocodazole (a tubulin toxin) or cytochalasin B (an actin toxin).
Both nocodazole and cytochalasin B impaired the adhesamine-induced cell
attachment, just as observed in the cells attached to fibronectin-coatedChemistry & Biology 16The other structural components of adhesamine are the two
terminal pyrimidine rings. Their removal completely eliminated
the effect on Jurkat cells (Figure 3B, molecule 4), indicating
that these aromatic groups are essential for activity. Reduction
of the aldehyde groups in the pyrimidine rings to hydroxyl groups
(molecule 5) had no impact on activity. This lack of impact and
the chemical tractability of the aldehyde group permitted the
introduction of a fluorescent dansyl group at the C5 position.
The dansyl conjugate of adhesamine (molecule 6) maintained
activity and served as a fluorescent probe.
Cell-Surface Glycosaminoglycans as Possible Targets
Fluorescence microscopic observation of molecule 6 revealed
its localization on the cell surface (Figure 3E). In contrast, a dansyl
conjugate of dispirotripiperazine (molecule 7), which exhibited
little effect on cell adhesion, showed no clear localization
(Figure 3F). The cell-surface localization ofmolecule 6 suggested
that adhesamine acts on the cell surface.
Candidates of the cell-surface targets were integrins, well-
known cell-surface receptors for extracellular matrix such as
fibronectin. To explore this possibility, we added to the medium
an Arg-Gly-Asp (RGD) peptide, which binds to and masks the
fibronectin-interacting domain of integrins, and examined its
ability to squelch the activity of adhesamine. The RGD peptide
reduced attachment of Jurket cells on a fibronectin-coated plate
but failed to inhibit the adhesamine-induced attachment of
Jurkat cells even at a high concentration (100 mg/ml) (Figure S6).
It is unlikely that adhesamine exerts its activity through interact-
ing with the fibronectin-recognition domain of integrins.
Other potential targets of adhesamine are GAGs (Schmidtke
et al., 2002), negatively charged cell-surface glycans that have
been reported to play an important role in cell adhesion together
with integrins (Bernfield et al., 1999; Gallagher, 1989; Cole and
McCabe, 1991; Gupta and Datta, 1991; Oohira et al., 2000).
Cell-surface GAGs include four major components—heparan
sulfate, chondroitin sulfate, keratan sulfate, and hyaluronic
acid. Excess amounts of each GAG were added to the medium,
and their ability to squelch the activity of adhesamine was exam-
ined (Mahalingam et al., 2007). Heparan sulfate and keratan
sulfate decreased adhesamine-induced cell adhesion in a
dose-dependent manner, with IC50 values of 0.79 and 1.03 mM,
respectively; IC50 values are defined as the concentrations of
oligosaccharides required for 50% inhibition of the adhesamine
(6 mM)–induced cell attachment. Chondroitin sulfate and hyalur-
onic acid had no detectable effect.
We also tested heparin, a soluble GAG analogous to heparan
sulfate that has more defined structures. Remarkably, the addi-
tion of this soluble GAG blocked the adhesamine-induced cell
attachment better than heparan sulfate did, with an IC50 value
of 0.27 mM.
To confirm the interactions, we performed isothermal titration
calorimetric (ITC) measurements of the binding of adhesamine to
each GAG (Hernaiz et al., 2002). Clear exothermic interactions
were observed for heparin, heparan sulfate, and keratan sulfate
plates. The toxins had limited effects on the nonspecific cell adhesion to
poly-L-lysine-coated plates. The concentration of adhesamine (1) was 6 mM.
The fibronectin- or poly-L-lysine-coated plates were prepared by pretreating
wells of 96-well plates with fibronectin or poly-L-lysine (1 ng/well)., 773–782, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 775
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Discovery and Mechanism of Adhesaminewith KD (dissociation constant) values of 0.39, 4.67, and 5.85 mM,
respectively (Table 1). Titrations with chondroitin sulfate and
hyaluronic acid failed to display signals strong enough for KD
estimation. These data suggest that adhesamine interacts selec-
tively with heparin, heparan sulfate, and keratan sulfate. The
interaction with heparin is the most tight, raising the possibility
that adhesamine binds to heparin-like segments of heparan
sulfate on the cell surface.
For detailed analyses of the interaction, we focused on heparin
as a model. Heparin is a linear polysaccharide essentially com-
posed of repeating disaccharide units (sulfated uronic acid-D-
glucosamine) (Gatti et al., 1979; Noti and Seeberger, 2005). To
define a minimal binding unit, interactions of adhesamine with
heparin oligosaccharides of various sizes (disaccharide, tetra-
saccharide, hexasaccharide, octasaccharide, and decasacchar-
ide) were examined by both squelching assays and ITC. In both
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Figure 3. Adhesion-Promoting Activities of
Adhesamine (1) and Its Derivatives (2–7)
(A and B) The ability of the derivatives to promote
cell adhesion was evaluated with Jurkat cells.
(C–F) Subcellular localization of fluorescent
probes 6 and 7. Brightfield (C and D) and confocal
(E and F) images are shown. HepG2 cells incu-
bated with molecule 6 (6 mM, C, E) or molecule 7
(6 mM, D, F) for 3 hr after seeding. We used
HepG2 cells for imaging analysis (C–F) and Jurkat
cells for adhesion experiments (A, B). HepG2 cells
were more suited for imaging analysis than were
Jurkat cells because of their size and flatter
shapes, whereas Jurkat cells were more suited
for adhesion analysis than were HepG2 cells
because of their nonadherent properties. Each
point represents the mean ± SD.
experiments, the hexasaccharide dis-
played the highest affinity for adhesamine
(Table 1). ITC results also revealed that
two molecules of adhesamine bind to
a hexasaccharide unit of heparin with
a KD value of 0.12 mM.
We also examined the interaction of
heparin or heparan sulfate with the
adhesamine derivatives that failed to
promote cell adhesion (molecules 2, 3,
and 4). Titration with heparin or heparan
sulfate generated no detectable heat
release for each molecule under the
same conditions as used for adhesamine
(1). The inability of these three molecules
to bind to heparin or heparan sulfate
supports our model in which adhesamine
promotes cell adhesion through interact-
ing with cell-surface heparan sulfate or
its heparin-like sequences.
Cell-Surface Heparan Sulfate
as a Target
To confirm that cell adhesion with adhes-
amine is mediated by cell-surface hep-
aran sulfate, Jurkat cells were treated with GAG-degrading
enzymes. Degradation of cell-surface heparan sulfate chains
with heparinase, heparitinase I, and heparitinase II (0.02 units/ml)
reduced the adhesamine-induced cell attachment. In contrast,
a 5-fold higher concentration (0.1 units/ml) of chondroitinase
ABC had no detectable effect on the adhesamine-induced cell
adhesion (Figure 4A). Digestion of heparan sulfate also affected
the attachment of cells to fibronectin-coated plates, although the
influence was less than it was for adhesamine-treated cells
(Figure 4A). This result is consistent with the previous finding
that fibronectin binds both integrins and heparan sulfate to
mediate cell adhesion.
We also examined the effects of these GAG-degrading
enzymes on the intact or adhesamine-enhanced attachment of
HepG2 cells. The intact attachment of HepG2 cells was slightly
impaired by treatment with GAGs-degrading enzymes: 13%776 Chemistry & Biology 16, 773–782, July 31, 2009 ª2009 Elsevier Ltd All rights reserved
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with heparinase/heparitinase I/heparitinase II (0.02 units/ml) or
chondroitinase ABC (0.1 units/ml), respectively (Figure S7). As
observed in Jurkat cells, adhesamine-induced cell adhesion
was canceled by heparan sulfate–degrading enzymes but not
by chondrotitinase ABC (Figure S7).
We also investigated the effects of the GAG-degrading
enzymes on localization of the fluorescent probe of adhesamine
(6). When cells were treated with heparan sulfate–degrading
enzymes,molecule 6was diffused from the cell surface, whereas
chondroitinase treatment exhibited no impact on the cell-surface
localization of molecule 6 (Figures 4D and 4E). These results
supports our notion that adhesamine induces cell adhesion
through its interaction with cell-surface heparan sulfate.
To further validate the interaction of adhesamine with heparan
sulfate, we used well-characterized CHO-K1 cell mutants defi-
cient in glycosaminoglycan synthesis, including CHO 745, CHO
677, CHO 606, and CHO F17. CHO 745 cells are unable to
synthesize heparan sulfate and chondroitin sulfate, and CHO
677 cells exhibit reduced expression of heparan sulfate and an
increase in chondroitin sulfate (Esko et al., 1985; Zhang and
Esko, 1995). Both of these cells lines were less responsive to
adhesamine than were parental CHO-K1 cells (Figure 4F). These
data indicate that the adhesamine-induced cell adhesion is
a heparan sulfate proteoglycan-dependent process and that
the absence of heparan sulfate cannot be compensated for by
increasing the level of expression of chondroitin sulfate.
CHO 606 cells, which lack GlcNAc N-deacetylase/N-sulfo-
transferase-1 activity, were also less responsive to adhesamine
(Figure 4D) (Bame and Esko, 1989). In contrast, 2-O-sulfotrans-
ferase-deficient CHO F17 cells responded to adhesamine
Table 1. Results of ITC Measurements and Squelching Assays
with GAGs
GAGs Kd (mM)
n (no. of
adhesamine
per GAGs) IC50 (mM)
a
Heparin (54 mer) 0.39 ± 0.09 20.34 ± 2.53 0.27 ± 0.05
Heparan sulfate
(59 mer)
4.67 ± 0.49 6.38 ± 0.49 0.79 ± 0.19
Keratan sulfate
(128 mer)
5.85 ± 4.75 33.28 ± 3.2 1.03 ± 0.11
Chondroithin
sulfate (218 mer)
NDb — >120
Hyaluronic acid
(600 mer)
NDb — >120
Disaccharide NDb — >120
Tetrasaccharide NDb — >120
Hexasaccharide 0.12 ± 0.03 2.16 ± 0.43 2.09 ± 0.13
Octasaccharide 0.45 ± 0.14 2.29 ± 0.17 2.18 ± 0.29
Decasaccharide 2.09 ± 0.14 3.42 ± 0.72 2.3 ± 0.2
Standard derivation is used for error bars. All data were collected in
50 mM phosphate buffer (pH 6.0) containing 100 mM NaCl and 1%
DMSO at 25C.
a IC50 values are defined as the concentrations of GAGs required for 50%
inhibition of the adhesamine (6 mM)–induced cell attachment.
bNot determined because of insufficient heat release.Chemistry & Biology 1(Figure 4D) (Bai and Esko, 1996). These results suggest that
N-sulfate groups in heparan sulfate are important elements for
the interaction with adhesamine, whereas sulfate groups at C-2
uronic acid residues are less crucial for binding.
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Figure 4. Validation of Cell-Surface Heparan Sulfate as a Target of
Adhesamine
(A) Effects of heparan sulfate–degrading enzymes on adhesamine-induced
adhesion of Jurkat cells. Cells were pretreated with 0.02 units/ml of heparin-
ase, heparitinase I, and heparitinase II or 0.1 units/ml of protease-free chon-
droitinase ABC in a serum-free medium for 1 hr at 37C before evaluating
cell adhesion. Treated cells were seeded onto adhesamine-added or fibro-
nectin-coated plastic wells, and attached cells were counted 5 hr after seed-
ing. The concentrations of adhesamine and fibronectin were 6 mMand 5 mg/ml,
respectively. Each point represents the means ± SD.
(B–E) Subcellular localization of fluorescent probe 6 in HepG2 cells treated
with chondroitinase ABC (B, D) or heparinase/heparitinase I/heparitinase II
(C, E). Both phase images (B, C) and confocal images (D, E) are shown.
(F) Activities of adhesamine in CHO-K1 and glycosaminoglycan-deficient
mutant cell lines. Adhesion of CHO-K1 and its mutant cell lines was evaluated
when 6 mMof adhesamine was added to the culture media. Cells were seeded
onto adhesamine-added or fibronectin-coated plastic wells. The concentra-
tions of adhesamine and fibronectin were 6 mM and 5 mg/ml, respectively.
Attached cells were counted 5 hr after seeding. Each point represents the
means ± SD. Typical structures of heparin/heparan sulfate are also shown.6, 773–782, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 777
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Cell adhesion mediated by integrins and cell-surface heparan
sulfate proteoglycans generates intercellular signals that stimu-
late a number of nonreceptor kinases. Phosphorylation of focal
adhesion kinase (FAK), the most prominent kinase activated by
cell adhesion to extracellular matrix, was monitored in the pres-
ence of adhesamine. Time course analysis of FAK activation in
Jurkat cells demonstrated FAK phosphorylation 5 hr after adhes-
amine stimulation (Figure 5A). The activation was dose depen-
dent, and 5 mg/ml of adhesamine was sufficient to phosphorylate
FAK, whereas poly-L-lysine failed to do so at the same concen-
tration (Figure 5B). The adhesamine-induced phosphorylation of
FAK was reduced when cells were incubated with a competitive
concentration of heparin (Figure 5C). The addition of the RGD
peptide, in contrast, had no detectable effects (Figure 5C).
Western blots performed in parallel showed no significant
change in the total FAK levels in the cell lysates (Maguire et al.,
1995).
Similar results were obtained with extracellular signal-regu-
lated kinase (ERK), a downstream kinase that is activated by
FAK: ERK was phosphorylated 5 hr after incubation with adhes-
amine, and its activation was blocked by the addition of excess
amounts of heparin (Figure 5). The activation of FAK and ERK
plays important roles in cell motility, cell growth, cytoskeletal
organization, and adhesion-dependent cell survival (Gilmore
and Burridge, 1996; Zhao et al., 1998). The phosphorylation of
these two kinases may account for the cytoskeletal-organizing
and growth-promoting activities of adhesamine.
Adhesamine as a New Reagent for Cell Biology
The effect of adhesamine on cell attachment of floating Jurkat
cells was compared with the effects of four commonly used
plate-coating reagents: type I collagen, fibronectin, poly-L-
lysine, and poly-L-ornithine. The addition of adhesamine to
the medium caused significantly greater attachment of Jurkat
cells than did the simple addition of the coating reagents
(Figure 6A). Although the addition of the two synthetic reagents
(poly-L-lysine and poly-L-ornithine) had little effect, cell adhesion
was enhanced by 3–6-fold by adding 5–50 mg/ml (6–60 mM) of
adhesamine. Similar activity was observed when the plastic
plate surface was precoated with adhesamine: coating with
adhesamine at 10 mg/well resulted in a greater enhancement of
cell adhesion than did coating with poly-L-lysine, fibronectin,
or poly-L-ornithine. In this case, type I collagen had a slightly
greater effect than did adhesamine (Figure 6B).
One possible application of adhesamine may be its use as
a reagent that boosts microinjection, since tight attachment of
cells to a plate is generally required for successful microinjection.
To test this possibility, we examined whether adhesamine
enables microinjection into Jurkat cells, an experiment that has
been considered technically difficult because of the nonadherent
characteristics of the lymphocytes. In fact, microinjection of
a fluorescent dye, Alexa Fluor 594, into the cells was completely
unsuccessful in the absence of adhesamine. The addition of type
I collagen or poly-L-lysine to the culture exhibited almost no
effect, and that of fibronectin improved the success rates by
up to 30% (Figure 6C). The addition of the same amounts of
adhesamine, however, boosted the success rates by as much
as 80% (Figure 6C) (a video clip of the microinjection is avail-778 Chemistry & Biology 16, 773–782, July 31, 2009 ª2009 Elsevieable in the Supplemental Data). Adhesamine may serve as
a synthetic reagent that enables or aids microinjection into
hard-to-inject cells.
DISCUSSION
To our knowledge, adhesamine represents the first nonpeptidic
organic molecule whose simple addition induces adhesion
of cells to culture plates. Remarkably, adhesamine not only
enhances adhesion of adherent HepG2 cells but also renders
floating Jurkat cells adherent to its substrates. We tested adhes-
aminewith a number of other cell types, includingHeLa, SK-BR3,
HEK293, CHO, and mouse ES cells, and found that adhesamine
A
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Figure 5. FAK and ERK Activation by Adhesamine
(A) Time course of FAK and ERK activation upon adhesamine treatment. Jurkat
cells were treated with adhesamine (6 mM) in a serum-poor medium (0.1%
FBS) for the indicated periods of time, and lysates of the treated cells were im-
munoblotted with antibodies against FAK phospho-tyrosine397 (pFAK), FAK,
ERK1/2 phospho-threonine202/tyrosine204 (pERK), or ERK.
(B) Jurkat cells were incubated for 5 hr with varied concentrations of adhes-
amine or poly-L-lysine. Cell lysates were immunoblotted with antibodies
against FAK phospho-tyrosine397 or FAK.
(C) Effects of excess amounts of heparin or an RGD peptide (100 mg/ml) on
the phosphorylation of FAK and ERK. The concentration of adhesamine (1)
was 6 mM.r Ltd All rights reserved
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exhibited different levels of response.
The integrin family of cell-surface receptors has long been
known to play an essential role in cell adhesion: these molecules
represent the principal receptors for extracellular matrix proteins
but also serve as transmenbrane bridges between extracellular
matrix and actin-containing filaments of the cytoskeleton.
However, it is now accepted that integrin activation is insufficient
for complete cell adhesion and for maintenance of cell survival.
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Figure 6. Utility of Adhesamine
The ability to promote attachment of Jurkat cells to plastic culture plates was
compared among adhesamine (1) and commonly used coating materials (type
I collagen, fibronectin, poly-L-lysine, and poly-L-ornithine). Adhered cells were
counted when each reagent was simply added to the culture medium (A) or
when the wells of plastic plates were coated with each reagent (B). The data
shown are means ± SD for a minimum of three experiments. Surface area
per well is 0.3 cm2. (C) Microinjection of a fluorescent dye (Alexa Fluor 594)
into Jurkat cells in the presence of adhesamine (1). Adhesamine increased
success rates of the microinjection more than type I collagen, poly-L-lysine
hydrochloride, and fibronectin did. The concentration of the reagents used
was 5 mg/ml. Each point represents the mean ± SD.Chemistry & Biology 16Accumulating evidence indicates that cell-surface glycosamino-
glycansmediate cell adhesion and sustained survival as well and
often synergize with integrin signaling (Jeong et al., 2001; Kapila
et al., 1999; Laterra et al., 1983; Schuksz et al., 2008; Sharma
et al., 1999).
Chemical and cell biological analyses indicate that adhes-
amine binds to selected cell-surface glycosaminoglycans, espe-
cially heparan sulfate, to exert its adhesion-enhancing activity.
However, it remains unclear how the interaction of adhesamine
with heparan sulfate promotes cell adhesion. Adhesamine may
bridge between heparan sulfate proteoglycans and plastic/glass
surfaces by interacting with both of them. However, it is unlikely
that adhesamine simply alters the physical properties of the cell
surface through electrostatic interactions. Unlike poly-L-lysine,
adhesamine induces apparently normal cell adhesion accompa-
nied by organized actin structures, focal adhesion, and activa-
tion of FAK/ERK kinases. Such normal adhesion, similar to
that of extracellular matrix, is usually induced by clustering of
integrins and heparan sulfate. One possibility is that the dumb-
bell-shaped molecule acts as a bridge among heparan sulfate
proteoglycans, leading to the clustering of heparan sulfate
proteoglycans.
The discovery of a heparan sulfate–binding small molecule is
not entirely new. It has recently been reported that surfen, a small
molecule originally used as an excipient for the production of
depot insulin, binds to heparan sulfate (Schuksz et al., 2008).
This aminoquinoline derivative acts as an antagonist of heparan
sulfate and heparin and thereby inhibits heparan sulfate–medi-
ated cell attachment. In contrast, adhesamine behaves like an
agonist of heparan sulfate, enhancing heparan sulfate–mediated
cell attachment. An important implication is that it is possible to
positively and negatively control heparan sulfate by small mole-
cules. Comparison of these two molecules would facilitate
mechanistic analysis of adhesamine and its analogs.
SIGNIFICANCE
Although further studies are needed for a complete under-
standing of the mechanism of action, adhesamine may serve
as a starting point for designing chemical tools to investi-
gate the roles of cell-surface glycosaminoglycans. This
new molecule also has potential for use as a reagent for
basic cell biology and cell engineering. Naturally derived,
extracellular matrix components, such as fibronectin and
collagen, have been extensively used as cell-adhesion
matrices for hard-to-culture cells and have contributed
significantly to bioengineering and basic cell biology
research. The drawbacks of such animal-derived materials
include the potential risk of disease transmission, relatively
low purity, and poor reproducibility and stability (Koide,
2005). These limitations can be overcome by the use of
synthetic materials. In fact, synthetic polycationic materials
and, more recently, biomimetic materials, including those
utilizing RGD peptides, antibodies, and carbohydrate, have
been developed and widely used to promote cell adhesion
(Hersel et al., 2003; Kobayashi et al., 1986). However, non-
peptidic, completely organic molecules that promote
normal cell adhesion and growth have never been reported,
to our knowledge. Adhesamine or its derivatives may, 773–782, July 31, 2009 ª2009 Elsevier Ltd All rights reserved 779
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naturally derived or peptidic materials.
EXPERIMENTAL PROCEDURES
Materials
Compound 4 (3,12-diaza-6,9-diazoniadispiro-(5,2,5,2)hexa-decane) was
obtained as dibromide salt from Sigma-Aldrich. The TFA salts of compounds
1–7 were dissolved in DMSO before being diluted to working concentrations
for the cell-adhesion assays and ITC experiments. Type I collagen from salmon
skin and fibronectin from bovine plasma (Wako Pure Chemicals), poly-L-lysine
hydrochloride (Peptide Institute. Inc.), and poly-L-ornithine hydrobromide (MP
Biomedicals, Inc.) were dissolved in Milli-Q water and stored at 20C until
required for use. Heparin (averagemolecularmass [Mw], 18.0 kDa) and heparan
sulfate (Mw, 13.6 kDa) were purchased as sodium salts from MP Biomedicals
Inc. and Celsus, respectively. Chondroitin sulfate A (Mw, 37.5 kDa), keratan
sulfate (Mw, 30.0 kDa), hyarulonic acid (Mw, 125.0 kDa), heparinase, hepariti-
nase I, heparitinase II, and chondroitinase ABC were obtained as sodium salts
from Seikagaku Corporation. Rhodamine phalloidin and Alexa Fluor 488 goat
anti-mouse immunoglobulin G (IgG) were obtained from Invitrogen.Monoclonal
anti-vinculin antibodywas obtained fromSigma-Aldrich. Nocodazole and cyto-
chalasin B were obtained from Wako Pure Chemicals. Rabbit anti-FAK (C-20)
antibody and rabbit anti-ERK (C-16) antibody were purchased for Santa Cruz
Biotechnology. Mouse anti-FAK (phospho-tyrosine397) antibody was obtained
from BD Biosciences PharMingen. Rabbit anti-ERK1/2 phospho-threonine202/
tyrosine204 (pERK) antibody was purchased from Cell Signaling Technology.
Anti-rabbit andanti-mouse IgG(horseradishperoxidase-linked,wholeantibody)
and ECL Plus Western blotting detection reagents were purchased from GE
Healthcare. Synthetic RGD-specific peptide (GRGDTP) was from Sigma.
Synthesis of Compounds 1–3, 5–7
Full experimental procedures and compound characterization data are
provided in the Supplemental Data.
Cell Culture and Small Molecule Screen
HepG2 cells were cultured inMEM supplementedwith 10% fetal bovine serum
(FBS) and 1% penicillin/streptomycin at 37C under humidified 5% CO2.
Jurkat cells were cultured in RPMI-1640 supplemented with 10% FBS and
1% penicillin/streptomycin at 37C under humidified 5% CO2. For the small
molecule screen, HepG2 cells (23 105 cells/ml) were plated into 96-well plates
and were treated individually with a 20 mg/ml compound in 100 ml of the culture
medium. After 3, 16, and 24 hr incubation, the cells were subjected to micro-
scopic observation. CHO K1 cells and CHO mutant cell lines were maintained
in Ham’s F-12 medium supplemented with 7.5% fetal bovine serum.
Cell Adhesion Assay
Addition
One microliter of adhesamine (1), Type I collagen, poly-L-lysine hydrochloride,
poly-L-ornithine hydrobromide, and fibronectin was added to 96-well plate at
a concentration of 50, 500, and 5000 mg/ml. HepG2 cells were suspended in
the growth medium, and 100 ml of cell suspension was added to each well
at a density of 43 105 cells/ml. After 3 hr incubation at 37C, nonadherent cells
were removed by washing with PBS three times, and the attached cells were
counted with a Neubauer counting chamber (Digital Bio) after trypsinization.
For Jurkat cells, 100 ml of cell suspension in the culture medium was added
to each well at a density of 1 3 106 cells/ml. After 5 hr of incubation at 37C,
nonadhered cells were removed by washing with PBS twice, and the attached
cells were countedwith aNeubauer counting chamber. For CHOwild-type and
mutant cell lines, 100 ml of trypsinized cell suspension in the culture medium
was added to each well at a density of 23 105 cells/ml. After 5 hr of incubation
at 37C, nonadhered cells were removed by washing with PBS twice, and the
attached cells were counted with a Neubauer counting chamber. To calculate
adhesion rates, the cell numbers before washing were assigned as a value of
100%. Each assay was conducted in triplicate, and the means and standard
derivations were calculated for a minimum of three independent experiments.
Coating
The working solutions of adhesamine (1), Type I collagen, poly-L-lysine hydro-
chloride, poly-L-ornithine hydrobromide, and fibronectin were prepared by780 Chemistry & Biology 16, 773–782, July 31, 2009 ª2009 Elsevierdiluting with PBS containing 1%DMSO. One hundred microliters of each solu-
tion (1, 10, and 100 mg/ml) was added to 96-well plates and incubated over-
night at 4C. One hundred microliters of cell suspension in a culture medium
was added to each well at a density of 13 106 cells/ml. After 5 hr of incubation
at 37C, nonadhered cells were removed by washing with PBS twice, and
attached cells were counted with a Neubauer counting chamber.
Squelching Assay
Adhesamine (1, 0.6 nmol) and each GAG (heparin, heparan sulfate, chondroitin
sulfate, keratan sulfate, hyaluronic acid, and heparin oligosaccharides) ranging
from 0.006 to 12 nmol were preincubated in 10 ml of 50 mM phosphate buffer
(pH 6.0) containing 100mMNaCl and 1%DMSO by stirring with a vortex mixer
at room temperature for 30 min. These mixtures were transferred to 96-well
plates, and 90 ml of Jurkat cell suspension (1 3 105 cells/ml) in growth culture
medium was added to each well. After 5 hr of incubation at 37C, nonadherent
cells were removed by washing with PBS three times, and the attached cells
were counted with a Neubauer counting chamber. IC50 values are defined
as the concentrations of GAGs required for 50% inhibition of the adhesamine
(6 mM)–induced cell attachment. The results of the squelching assays were
plotted as percentage of inhibition versus log [GAG], and IC50 values were
determined from curve fits of multiple independent experiments.
Isothermal Titration Calorimetry
ITC experiments were performed at 25C using a MicoCal VP-ITC microcalo-
rimeter. Adhesamie (1, 15 mM) and its derivatives of (2, 3 and 4, 15 mM) were
titrated with 253 10 ml injections of GAGs (2.7 mM of heparan sulfate, heparin,
chondroitin sulfate, hyaluronic acid, and heparin oligosaccharides). The titra-
tions were performed in 50 mM phosphate buffer (pH 6.0) containing
100 mM NaCl and 1% (v/v) DMSO. The concentrations of GAGs are given
as the concentrations of their disaccharide units.
Cell Detachment Assay
One microliter of DMSO solution of adhesamine (1) (6 mM) was dispensed to
each well on a 96-well plate. Jurkat cells were suspended in the growth
medium, and 100 ml of cell suspension was added to each well at a density
of 13 106 cells/ml. After 5 hr of incubation at 37C, the mediumwas aspirated,
and the plates were washed twice with PBS; 100 ml of fresh medium was
added to each well. After further 4, 8, 14, and 24 hr incubation at 37C, nonad-
hered cells were removed by washing with PBS twice, and the attached cells
were counted with a Neubauer counting chamber. To calculate adhesion
rates, the cell numbers before washing were assigned as a value of 100%.
Each assay was conducted in triplicate, and the means and standard deriva-
tions were calculated for a minimum of three independent experiments.
Subcellular Localization of 6 and 7
HepG2 cells were seeded on a 96-well microplate (Greiner) at a density of 23
105 cells/ml, and the cells were incubated with the solution of compounds 6 or
7 for 3 hr at 37C at the concentration of 6 mM. After incubation, the medium
was replaced with fresh growth medium, and the cells were then subjected
to fluorescent microscopic observation. Fluorescence images of the cells
were captured by a Yokogawa CSU22 confocal fluorescence microscope
with 405 nm laser excitation.
Enzymatic Treatment of Cells
Jurkat cells (53 104) were cultured in 100 ml of RPMI and treated with a combi-
nation of heparinase, heparitinase I, and heparitinase II (0.02 units/ml) or chon-
droitinase ABC (0.1 units/ml) for 30 min at room temperature. The ability of the
treated cells to respond to adhesamine was evaluated by counting the cells
that were attached to plastic wells of a 96-well plate in the presence of adhes-
amine (6 mM).
Cell Growth Assay
One microliter of DMSO solution of adhesamine (1) was added to a 96-well
plate at a concentration of 600 mM. HepG2 cells and Jurkat cells were sus-
pended in the growth medium, and 100 ml of cell suspension was added to
each well at a density of 23 105 and 43 105 cells/ml, respectively. After incu-
bation for the indicated time, the cell viability was measured using Cell Count-
ing Kit-8 (Dojindo Molecular Technologies, Inc., Gaithersburg, MD), whichLtd All rights reserved
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dye by NADH dehydrogenases in living cells. Five microliters of WST-8 assay
solution was added to 100 ml of the growthmedium per well andwas incubated
for 4 hr. The optical density (OD) of the solution was read by a microplate
reader, using a test wavelength at 450 nm and a reference wavelength at
650 nm. The cell viability incubated in the growth medium containing 1% (v/v)
of DMSOwas assigned as a value of 100%. Each assay was conducted in trip-
licate, and the means and standard derivations were calculated for a minimum
of three independent experiments.
Visualization of Cytoskeletal Rearrangement
Jurkat or HepG2 cells were plated onto glass coverslips in the presence of
adhesamine (6 mM). They were fixed after 5 or 3 hr, respectively, with 4% para-
formaldehyde for 20 min. The cell membrane was permeabilized by a 5-min
treatment with 0.1% Triton X-100 (in PBS). Samples were washed twice with
PBS, and actin cytoskeleton was visualized with rhodamine-conjugated phal-
loidin according to the manufacturer’s instruction (Invitrogen). The cell images
were captured with a Yokogawa CSU22 confocal fluorescence microscope
with 568-nm laser excitation.
Immunofluorescent Staining of Vinculin
Jurkat cells were plated onto glass coverslips in the presence of adhesamine
(6 mM) and incubated for 5 hr. They were fixed with 4% paraformaldehyde for
30 min, treated with 0.1% Triton X-100 in PBS, and incubated with blocking
solution (PBS containing 3% FBS) for 60 min. Blocking solution was removed,
and cells were incubated overnight with anti-vinculin monoclonal antibody.
Cells were washed and then were incubated with Alexa Fluor 488-conjugated
goat anti-mouse IgG in blocking solution. After extensive washing, the cell
images were captured with a Yokogawa CSU22 confocal fluorescence micro-
scope with 488-nm laser excitation.
Cytoskeletal Disruption
Jurkat cells (53 104) were cultured in 100 ml of RPMI and were incubated with
cytochalasin B (0–100 mM) or nocodazole (0–0.5 mM) for 37C. The treated cells
were then assayed for their responses to adhesamine (6 mM). Their responses
to fibronectin- or poly-L-lysine-coated plates were also evaluated. The coated
plates were prepared by pretreating wells of 96-well plates with fibronectin or
poly-L-lysine (1 ng/well).
Western Blotting
Jurkat cells were maintained in an RPMI medium containing 10% FBS and
were resuspended in a serum-free RPMI medium. Five to six million Jurkat
cells were dispensed to a well of a 6-well plate in a final volume of 2 ml and
then were incubated at 37C for 0–5 hr in the presence of adhesamine or
poly-L-lysine. Nonadherent cells were removed and pelleted, and the remain-
ing adherent cells were lysed in a 125 mM Tris-HCl buffer (pH 6.8) containing
4% SDS, 10% glycerol, 0.006% bromophenol blue, and 1.8% b-mercaptoe-
thanol. The adherent cell homogenate was combined with pelleted nonadher-
ent cells from the same well, and the combined sample was boiled for 5 min.
The samples were separated by SDS-PAGE and electroblotted onto a nitrocel-
lulose membrane. The membranes were blocked in 1% BSA and incubated
with primary antibody, and then with horseradish peroxidase–conjugated
secondary antibody. The blots were developed using the enhanced chemilu-
minescence technique.
Microinjection
The solutions of adhesamine (1), Type I collagen, poly-L-lysine hydrochloride,
and fibronectin were prepared by diluting with PBS containing 1% (v/v) DMSO.
Ten microliters of each solution (1 mg/ml) was added to glass-bottom culture
dishes (35 mm uncoated dish). Two milliliters of cell suspension in a culture
medium was added to each well at a density of 2 3 105 cells/ml. After 14 hr
of incubation at 37C, Alexa Fluor 594 (Molecular Probes, USA) at a concentra-
tion of 5 mg/ml was injected into Jurkat cells by using a CI-2000 automated
cell injection system (Fujitsu, Japan). Success rates of the microinjection
were evaluated by direct observation of the fluorescent cells through a fluores-
cent-microscopic window of the injection system. The data shown are
means ± SD for a minimum of three experiments. Twenty cells were injected
in each experiment.Chemistry & Biology 1SUPPLEMENTAL DATA
Supplemental data include seven figures, Supplemental Experimental Proce-
dures, and one movie and can be found with this article online at http://www.
cell.com/chemistry-biology/supplemental/S1074-5521(09)00206-3.
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